![John Hamill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Hamill
Director of Finance/CFO at
APREA THERAPEUTICS, INC.
Net worth: 26 852 $ as of 31/05/2026
Profile
Mr. John P.
Hamill, CPA, is a Secretary, Chief Financial & Accounting Officer at Aprea Therapeutics, Inc., a Chairman at CVie Therapeutics Ltd., a Member at Pennsylvania Institute of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
Mr. Hamill was previously employed as a Chief Financial Officer, Secretary & Treasurer by Windtree Therapeutics, Inc., a Vice President-Finance by Trevena, Inc., an Interim Chief Financial Officer by Cellectar Biosciences, Inc., a CEO, CFO, Secretary & Treasurer by NephroGenex, Inc., a Co-President & Chief Financial Officer by Savient Pharmaceuticals, Inc., a Chief Financial Officer & Executive Vice President by Pharmanet Development Group, Inc., a Principal by Johnson & Johnson, and a Principal by Rhone-Poulenc Pharmaceuticals North America.
He received his undergraduate degree from DeSales University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/04/2026 | 30,069 ( 0.24% ) | 26 852 $ | 31/05/2026 |
John Hamill active positions
| Companies | Position | Start |
|---|---|---|
| APREA THERAPEUTICS, INC. | Director of Finance/CFO | 30/01/2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Pennsylvania Institute of Certified Public Accountants
 Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Corporate Officer/Principal | - |
CVie Therapeutics Ltd.
 CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Chairman | - |
Former positions of John Hamill
| Companies | Position | End |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Director of Finance/CFO | 27/01/2023 |
| TREVENA, INC. | Comptroller/Controller/Auditor | 01/08/2018 |
| CELLECTAR BIOSCIENCES, INC. | Director of Finance/CFO | 01/04/2018 |
| NEPHROGENEX INC | Chief Executive Officer | 01/05/2017 |
| SAVIENT PHARMACEUTICALS INC | Director of Finance/CFO | 01/01/2014 |
Training of John Hamill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
DeSales University
 DeSales University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Commercial Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Rhone-Poulenc Pharmaceuticals North America | |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
- Stock Market
- Insiders
- John Hamill
